CRVO logo
CRVO NASDAQ US

CervoMed Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Nov 2016
$4.14
▲ +$0.14 (+3.50%)
Vol 72K
4
Quality Score
fail
Mkt Cap
$73.1M
ROE
-76.8%
Margin
-487.7%
D/E
0.00
Beta
-0.91
52W
$2–$17

Wall Street Consensus

14 analysts · Apr 2026
2
Strong Buy
11
Buy
1
Hold
0
Sell
0
Strong Sell
92.9%
Buy Rating

Price Chart

Similar Stocks

ALGS
Aligos Therapeutics Inc
$57.4M
ATRA
Atara Biotherapeutics Inc
P/E 5.6
$130.4M
LITS
Lite Strategy Inc
$48.6M
SNSE
Sensei Biotherapeutics Inc
$13.5M
CELU
Celularity Inc
$31.6M
NXTC
NextCure Inc
$49.7M
RNXT
RenovoRx Inc
$30.8M
PDSB
PDS Biotechnology Corp
$42.1M

Earnings

Beat rate: 25.0%
Next Report May 11, 2026
EPS Estimate: $-0.80
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.80 — —
Dec 2025 $-0.73 $-0.88 $-0.15
Sep 2025 $-0.79 $-0.84 $-0.05
Jun 2025 $-0.64 $-0.70 $-0.06

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -59.2% -59.2% -59.2% -59.2% -76.8% -76.8%
P/E (TTM) — — — — — —
Net Margin -356.1% -302.4% -302.4% -302.4% -487.7% -487.7%
Gross Margin — -230.4% -230.4% -230.4% -230.4% -230.4%
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 8.20 8.20 8.20 8.20 6.66 6.66

Key Ratios

ROA (TTM)
-68.1%
P/S (TTM)
17.23
P/B
0.5
EPS (TTM)
$-2.87
CF/Share
$-1.84
Rev Growth 3Y
+418.2%
52W High
$16.94
52W Low
$1.92
$1.92 52-Week Range $16.94

How does CRVO compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

CRVO AAPG ABEO ABOS ABP

CRVO valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
17.2
▲ 34% above peers (12.9)
vs Peers
vs Industry
Pricier
P/B ratio
0.5
▼ 80% below peers (2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

CRVO profitability vs Biotechnology peers

ROE
-76.8%
▼ 14% below peers (-67.3%)
vs Peers
vs Industry
In line
Net margin
-487.7%
▼ 70% below peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
-230.4%
▼ 393% below peers (78.6%)
vs Peers
vs Industry
Weak
ROA
-68.1%
▼ 46% below peers (-46.7%)
vs Peers
vs Industry
Weak

CRVO financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
6.7
▲ 50% above peers (4.4)
vs Peers
vs Industry
Below avg
Beta
-0.9
▼ 194% below peers (1.0)
vs Peers
vs Industry
More volatile

CRVO fundamentals radar

CRVO Peer median Industry

CRVO profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

CRVO vs peers: key metrics

Latest News

No related news yet